CMS Suggests Noncoverage of Boston Sci Wingspan, Except In Clinical Trials
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific's Wingspan intracranial stent would not be covered by Medicare except during FDA-cleared clinical trials, according to a 1CMS proposed rule issued Aug. 9